Male breast cancer.
Although male breast cancer (MBC) is rare (<1% of all BC), its reported incidence has been rising. In addition to traditional risk factors, there is now known to be a 7% life-time risk in carriers of BRCA2. This article discusses the clinical and histological presentation of MBC and reviews the main treatments.
Joseph
Antony
A
St. George's Hospital, London, UK.
Mokbel
Kefah
K
D018567:Breast Neoplasms, Male / Q000453:epidemiology* / Q000235:genetics* / Q000517:prevention & control / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000453:epidemiology / Q000235:genetics; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D006801:Humans; D015994:Incidence; D008297:Male; D018570:Risk Assessment; D012307:Risk Factors; D014481:United States / Q000453:epidemiology